SwedenSweden to switch to protein-based COVID-19 vaccines from 2027/28
Sweden will transition to protein-based COVID-19 vaccines, moving away from mRNA vaccines like Pfizer and Moderna starting with the 2027/2028 vaccination season.
Background
The COVID-19 pandemic led to rapid vaccine development, primarily mRNA technology. As the global health crisis evolves, some countries are re-evaluating their long-term vaccination strategies and vaccine types.
Quorum · collective opinions
Sweden to switch to protein-based COVID-19 vaccines from 2027/28
First report 3h agoLast update 3h ago1 takes 1
factual reportingneutralShow 1 post
started 3h ago•Last update 3h ago
Reporting on Sweden's decision to adopt protein-based vaccines and the technical differences from mRNA vaccines.
iWitness comments
No comments yet — be the first to weigh in.